Association Between High Blood Folate Levels and Glaucoma in a Representative Korean Population.
Summary
Our findings indicate a strong inverse correlation between blood folate levels and glaucoma.
Abstract
PURPOSE
This study aimed to investigate the association between folate levels and the prevalence of glaucoma.
METHODS
This nationwide population-based cross-sectional study included 1790 participants aged ≥40 years. We analyzed data regarding the participants obtained in the 2016-2018 Korean National Health and Nutrition Examination Survey. The diagnosis of glaucoma was defined according to the International Society of Geographical and Epidemiological Ophthalmology criteria. Logistic regression analyses were used to investigate the relationship between blood folate levels and glaucoma.
RESULTS
There was a significantly lower prevalence of glaucoma in the highest quartile of blood folate levels than in the lowest quartile, after adjusting for confounding factors such as age, sex, systemic hypertension, diabetes, hypercholesterolemia, and smoking (odds ratio [OR] = 0.470; 95% confidence interval [CI], 0.291-0.759; P for trend = 0.017). There was a significantly lower risk of glaucoma in the highest quartile of blood folate levels than in the lowest quartile among women (OR = 0.188; 95% CI, 0.099-0.357; P for trend <0.001) and younger participants (OR =0.443; 95% CI, 0.229-0.856; P for trend = 0.045).
CONCLUSIONS
Our findings indicate a strong inverse correlation between blood folate levels and glaucoma.
More by Ji Young Lee
View full profile →Impact of Antiviral Therapy in Cytomegalovirus-Positive Anterior Uveitis: Recurrence Risk and Corneal Endothelial Cell Protection.
Risk Factors for Disease Progression in Glaucoma Patients With Disk Hemorrhage.
Impact of glaucoma surgery on recurrence rate in cytomegalovirus anterior uveitis.
Top Research in Epidemiology & Genetics
Browse all →The Risks and Benefits of Myopia Control.
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Neuroprotective strategies for retinal disease.
In the Knowledge Library
Discussion
Comments and discussion will appear here in a future update.